Lepu Medical announced that its subsidiary Sichuan Xingtai Pule Medical Technology Co., Ltd. has independently developed an injectable cross-linked sodium hyaluronate gel that has received registration approval from the National Medical Products Administration. This product is suitable for injection into the mid to deep dermal tissue of the facial nasolabial fold area to correct moderate to severe nasolabial fold wrinkles. The approval of this product further enriches the company's product matrix in the dermatology field and is expected to have a positive impact on the company's development. However, the specific sales situation of the new product after its launch may be affected by various factors, and the impact on the company's future performance is uncertain